Skip to main content Accessibility help
×
Home

Hepatitis B and C co-infection in HIV/AIDS population in the state of Michigan

  • Z. A. BUTT (a1) (a2), M. J. WILKINS (a3), E. HAMILTON (a4), D. TODEM (a1), J. C. GARDINER (a1) and M. SAEED (a1) (a5)...

Summary

A retrospective cohort study was conducted from 1 January 2006 to 31 December 2009 in Michigan to estimate the prevalence of HIV and hepatitis co-infection and identify associated factors. The prevalence of co-infection was 4·1% [95% confidence interval (CI) 3·8–4·5]. Multivariable logistic regression analysis revealed a significant association between co-infection and being male and: of Black race [odds ratio (OR) 2·0, 95% CI 1·2–3·6] and of Other race (OR 3·5, 95% CI 1·7–7·0) compared to Hispanic race. A significant association was found between co-infection and risk categories of blood products (OR 11·1, 95% CI 6·2–20·2), injecting drug user (IDU) (OR 3·6, 95% CI 2·7–4·8) and men who have sex with men/IDU (OR 3·4, 95% CI 2·4–4·9) in addition to two interactions; one between sex and current HIV status and the other between current HIV status and age at HIV diagnosis. Our results document the changing epidemiology of HIV–hepatitis co-infection which can guide preventive measures and interventions to reduce the prevalence of hepatitis co-infection.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Hepatitis B and C co-infection in HIV/AIDS population in the state of Michigan
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Hepatitis B and C co-infection in HIV/AIDS population in the state of Michigan
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Hepatitis B and C co-infection in HIV/AIDS population in the state of Michigan
      Available formats
      ×

Copyright

Corresponding author

*Author for correspondence: Dr Z. A. Butt, Department of Epidemiology and Biostatistics, B601 West Fee Hall, Michigan State University, East Lansing, MI 48824, USA. (Email: zabutt3@yahoo.com)

References

Hide All
1.Global Report. UNAIDS report on the Global AIDS epidemic, 2010 (http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2010/20101123_globalreport_en.pdf). Accessed 24 January 2010.
2.UNAIDS. United States of America. HIV and AIDS estimates 2009 (http://www.unaids.org/en/regionscountries/countries/unitedstatesofamerica/). Accessed 24 January 2010.
3.Michigan Department of Community Health. Quarterly HIV/AIDS report, Michigan. October 2010 (http://www.michigan.gov/documents/mdch/Oct_2010_335648_7.pdf). Accessed 2 January 2011.
4.WHO. Hepatitis B (http://www.who.int/mediacentre/factsheets/fs204/en/). Accessed 30 October 2009.
5.WHO. Hepatitis C: disease burden (http://www.who.int/vaccine_research/documents/Viral_Cancers.pdf). Accessed 30 October 2009.
6.CDC. Hepatitis B information for health professionals. (http://www.cdc.gov/hepatitis/HBV/HBVfaq.htm#overview). Accessed 28 October 2009.
7.Michigan Acute Hepatitis B Surveillance Summary, 2008. (http://www.michigan.gov/documents/mdch/Acute_Hepatitis_B_Surveillance_Summary_2008_289340_7.pdf). Accessed 10 November 2009.
8.Michigan Chronic Hepatitis B Surveillance Summary, 2008 (http://www.michigan.gov/documents/mdch/Chronic_Hepatitis_B_Surveillance_Summary_2008_289337_7.pdf). Accessed 10 November 2009.
9.CDC. Hepatitis C information for health professionals (http://www.cdc.gov/hepatitis/HCV/HCVfaq.htm#section1). Accessed 28 October 2009.
10.Michigan Acute Hepatitis C Surveillance Summary, 2008 (http://www.michigan.gov/documents/mdch/Acute_Hepatitis_C_Surveillance_Summary_2008_289339_7.pdf). Accessed 10 November 2009.
11.Michigan Chronic Hepatitis C Surveillance Summary, 2008 (http://www.michigan.gov/documents/mdch/Chronic_Hepatitis_C_Surveillance_Summary_2008_289342_7.pdf). Accessed 10 November 2009.
12.Sherman, KE, et al. Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clinical Infectious Diseases 2002; 34: 831837.
13.Puoti, M, et al. Hepatitis B virus co-infection in human immunodeficiency virus-infected subjects. AIDS Reviews 2002; 4: 2735.
14.Bodsworth, NJ, Cooper, DA, Donovan, B. The influence of humanimmunodeficiency virus type 1 infection on the development of the hepatitis B carrier state. Journal of Infectious Diseases 1991; 163: 11381140.
15.2010 Epidemiologic Profile of HIV/AIDS in Michigan (http://www.michigan.gov/documents/mdch/2010_EPI_PROFILE_ENTIRE_335483_7.pdf). Accessed 24 January 2010.
16.Michigan Department of Community Health. Epidemiologic profiles of HIV/AIDS in Michigan (http://michigan.gov/mdch/0,1607,7-132-2944_5320_5331-36307–,00.html). Accessed 6 April 2008.
17.CDC. Hepatitis B, acute (http://www.cdc.gov/ncphi/disss/nndss/casedef/hepatitisb2000.htm). Accessed 28 October 2009.
18.CDC. Chronic hepatitis B virus (http://www.cdc.gov/ncphi/disss/nndss/casedef/hepatitisbcurrent.htm). Accessed 28 October 2009.
19.CDC. Hepatitis C virus infection, acute (http://www.cdc.gov/ncphi/disss/nndss/casedef/hepatitiscacutecurrent.htm). Accessed 28 October 2009.
20.CDC. Hepatitis C virus infection, past or present (http://www.cdc.gov/ncphi/disss/nndss/casedef/hepatitisccurrent.htm). Accessed 28 October 2009.
21.Portelinha, Filho AM, et al. Seroprevalence of HBV, HCV and HIV co-infection in selected individuals from state of São Paulo, Brazil. Memorias do Instituto Oswaldo Cruz 2009; 104: 960963.
22.Anon. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbidity and Mortality Weekly Report. Recommendations and Reports 1992; 41: 119.
23.Kellerman, SE, et al. Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects. Journal of Infectious Disease 2003; 188: 571577.
24.Chun, HM, et al. Epidemiology of hepatitis B virus infection in a US cohort of HIV-infected individuals during the past 20 years. Clinical Infectious Diseases 2010; 50: 426436.
25.Anderson, KB, Guest, JL, Rimland, D. Hepatitis C virus coinfection increases mortality in HIV-infected patients in the highly active antiretroviral therapy era: data from the HIV Atlanta VA Cohort Study. Clinical Infectious Diseases 2004; 39: 15071513.
26.Barth, RE, et al. Hepatitis B/C and HIV in sub-Saharan Africa: an association between highly prevalent infectious diseases. A systematic review and meta-analysis. International Journal of Infectious Diseases 2010; 14: e10241031.
27.Kuniholm, MH, et al. Risk factors and algorithms to identify hepatitis C, hepatitis B, and HIV among Georgian tuberculosis patients. International Journal of Infectious Diseases 2008; 12: 5156.
28.Dwyre, DM, Fernando, LP, Holland, PV. Hepatitis B, hepatitis C and HIV transfusion-transmitted infections in the 21st century. Vox Sanguinis 2011; 100: 9298.
29.Victoria, MB, et al. Epidemiology of HIV/HCV coinfection in patients cared for at the Tropical Medicine Foundation of Amazonas. Brazilian Journal of Infectious Diseases 2010; 14: 135–40.
30.Reuter, S, et al. Prevalence and characteristics of hepatitis B and C virus infections in treatment-naïve HIV-infected patients. Medical Microbiology and Immunology 2011; 200: 3949.
31.Lincoln, D, Petoumenos, K, Dore, GJ. Australian HIV observational database. HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy. HIV Medicine 2003; 4: 241249.
32.Tedaldi, EM, et al. Prevalence and characteristics of hepatitis C virus coinfection in a human immunodeficiency virus clinical trials group: the Terry Beirn Community Programs for Clinical Research on AIDS. Clinical Infectious Diseases 2003; 36: 13131317.
33.Dorrucci, M, et al. The effect of hepatitis C on progression to AIDS before and after highly active antiretroviral therapy. AIDS 2004; 18: 23132318.
34.Romeo, R, et al. Hepatitis C is more severe in drug users with human immunodeficiency virus infection. Journal of Viral Hepatitis 2000; 7: 297301.
35.Goodenow, C, Netherland, J, Szalacha, L. AIDS-related risk among adolescent males who have sex with males, females, or both: evidence from a statewide survey. American Journal of Public Health 2002; 92: 203210.
36.Montgomery, SB, et al. Gender differences in HIV risk behaviors among young injectors and their social network members. American Journal of Drug and Alcohol Abuse 2002; 28: 453475.
37.Colvin, H, Mitchell, A. Committee on the Prevention and Control of Viral Hepatitis Infections, 2010. Institute of Medicine. Hepatitis and Liver Cancer: a National Strategy for Prevention and Control of Hepatitis B and C.

Keywords

Hepatitis B and C co-infection in HIV/AIDS population in the state of Michigan

  • Z. A. BUTT (a1) (a2), M. J. WILKINS (a3), E. HAMILTON (a4), D. TODEM (a1), J. C. GARDINER (a1) and M. SAEED (a1) (a5)...

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed